203 related articles for article (PubMed ID: 33251493)
1. Enhancing the Therapeutic Efficacy of Bone Marrow-Derived Mononuclear Cells with Growth Factor-Expressing Mesenchymal Stem Cells for ALS in Mice.
Terashima T; Kobashi S; Watanabe Y; Nakanishi M; Honda N; Katagi M; Ohashi N; Kojima H
iScience; 2020 Nov; 23(11):101764. PubMed ID: 33251493
[TBL] [Abstract][Full Text] [Related]
2. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.
Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V
J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of host and graft after cell sheet transplantation: Basic study for the application of amyotrophic lateral sclerosis.
Nakanishi M; Watanabe Y; Honda N; Une M; Kazuki K; Kazuki Y; Terashima T; Katagi M; Nakashima K; Hanajima R
Brain Res; 2019 Dec; 1724():146444. PubMed ID: 31518575
[TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
7. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
8. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.
Sironi F; Vallarola A; Violatto MB; Talamini L; Freschi M; De Gioia R; Capelli C; Agostini A; Moscatelli D; Tortarolo M; Bigini P; Introna M; Bendotti C
Stem Cell Res; 2017 Dec; 25():166-178. PubMed ID: 29154076
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.
Ohta Y; Nagai M; Miyazaki K; Tanaka N; Kawai H; Mimoto T; Morimoto N; Kurata T; Ikeda Y; Matsuura T; Abe K
Cell Med; 2011; 2(2):69-83. PubMed ID: 26998403
[TBL] [Abstract][Full Text] [Related]
10. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
12. [Effect of transplantation of wild-type bone marrow stem cells in mouse model of familial amyotrophic lateral sclerosis].
Huang H; Zhang C; Zhao CP; Yao XL; Xi J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):562-6. PubMed ID: 16995314
[TBL] [Abstract][Full Text] [Related]
13. Suppression of MicroRNA-383 Enhances Therapeutic Potential of Human Bone-Marrow-Derived Mesenchymal Stem Cells in Treating Spinal Cord Injury via GDNF.
Wei GJ; An G; Shi ZW; Wang KF; Guan Y; Wang YS; Han B; Yu EM; Li PF; Dong DM; Wang LP; Teng ZW; Zhao DL
Cell Physiol Biochem; 2017; 41(4):1435-1444. PubMed ID: 28365701
[TBL] [Abstract][Full Text] [Related]
14. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol.
Yun YC; Jeong SG; Kim SH; Cho GW
J Tissue Eng Regen Med; 2019 Jan; 13(1):110-115. PubMed ID: 30479062
[TBL] [Abstract][Full Text] [Related]
15. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
[TBL] [Abstract][Full Text] [Related]
16. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.
Forostyak S; Jendelova P; Sykova E
Biochimie; 2013 Dec; 95(12):2257-70. PubMed ID: 23994163
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Effects of Suppression of MicroRNA-383 in Human Bone-Marrow-Derived Mesenchymal Stem Cells on Treating Spinal Cord Injury.
Wei GJ; Zheng KW; An G; Shi ZW; Wang KF; Guan Y; Wang YS; Li PF; Dong DM
Cell Physiol Biochem; 2018; 47(1):129-139. PubMed ID: 29763918
[TBL] [Abstract][Full Text] [Related]
18. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.
Lunn JS; Hefferan MP; Marsala M; Feldman EL
Growth Factors; 2009 Jun; 27(3):133-40. PubMed ID: 19294549
[TBL] [Abstract][Full Text] [Related]
19. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Suzuki M; Svendsen CN
Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the survival of bone marrow-derived mononuclear cells and the growth factors produced upon intramedullary transplantation in rat models of acute spinal cord injury.
Arai K; Harada Y; Tomiyama H; Michishita M; Kanno N; Yogo T; Suzuki Y; Hara Y
Res Vet Sci; 2016 Aug; 107():88-94. PubMed ID: 27473980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]